25 Posts Not To Miss From ASCO 2026 Day 4
Yvonne Awards 2026 Honored Leaders Shaping the Future of Oncology
AEGEAN Trial: Durvalumab Reshapes the Tumor Microenvironment in Resectable NSCLC
Is RAS No Longer Undruggable? Discussions on RASolute Trial That Earned Standing Ovation at ASCO26
New Trial Tests Trabectedin With Radiotherapy in Retroperitoneal L-Sarcoma
International Partnerships Aim to Mitigate Cancer Care Disruptions in Ukraine - AACR
A Year to Remember at ASCO 26 - GI Cancers Alliance
HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer
